New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2013
16:19 EDTBABY, ISILNatus Medical appoints Jonathan Kennedy as CFO
Natus Medical (BABY) announced it has named Jonathan Kennedy, former CFO of Intersil (ISIL), to the position of senior vice president and CFO. Kennedy is expected to join Natus on April 8. At that time he will assume the CFO role currently held by Steven J. Murphy, who will remain with the company as vice president finance, a position he has held since 2003.
News For BABY;ISIL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
09:05 EDTISILIntersil M&A potential should support shares, says Susquehanna
Susquehanna said Intersil's disappointing Q2 results were not a surprise as they had seen weakness in Asia and lowered their estimate accordingly. The firm believes management will mitigate its current revenue weakness through cost controls and noted its mention as a potential M&A candidate should provide a floor for shares. Susquehanna maintained its Positive rating but lowered its price target to $14 from $18 on Intersil shares.
July 29, 2015
16:16 EDTISILIntersil sees Q3 adjusted EPS 12c-15c, consensus 18c
Subscribe for More Information
16:15 EDTISILIntersil reports Q2 adjusted EPS 16c, consensus 16c
Subscribe for More Information
July 23, 2015
09:21 EDTBABYNatus Medical price target raised to $51 from $45 at Roth Capital
Subscribe for More Information
July 22, 2015
06:08 EDTBABYNatus Medical raises FY15 non-GAAP EPS view to $1.50-$1.52 from $1.47-$1.51
Subscribe for More Information
06:07 EDTBABYNatus Medical sees Q3 non-GAAP EPS 37c-38c, consensus 39c
Subscribe for More Information
06:05 EDTBABYNatus Medical reports Q2 non-GAAP EPS 34c, consensus 32c
Reports Q2 revenue $91.9M, consensus $90.83M. Reports Q2 constant currency revenue $93.4M after adjusting for a $1.5M foreign currency impact.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use